Tompkins Financial Corp decreased its stake in Danaher Corporation (NYSE:DHR) by 0.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,570 shares of the conglomerate’s stock after selling 80 shares during the period. Tompkins Financial Corp’s holdings in Danaher Corporation were worth $892,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. ProShare Advisors LLC raised its position in Danaher Corporation by 2.4% in the first quarter. ProShare Advisors LLC now owns 88,623 shares of the conglomerate’s stock valued at $7,580,000 after buying an additional 2,076 shares in the last quarter. Profund Advisors LLC raised its position in Danaher Corporation by 11.4% in the first quarter. Profund Advisors LLC now owns 24,796 shares of the conglomerate’s stock valued at $2,121,000 after buying an additional 2,538 shares in the last quarter. Fisher Asset Management LLC raised its position in Danaher Corporation by 1.9% in the first quarter. Fisher Asset Management LLC now owns 5,224 shares of the conglomerate’s stock valued at $447,000 after buying an additional 97 shares in the last quarter. Korea Investment CORP raised its position in Danaher Corporation by 96.9% in the first quarter. Korea Investment CORP now owns 464,086 shares of the conglomerate’s stock valued at $39,693,000 after buying an additional 228,351 shares in the last quarter. Finally, Intermede Investment Partners Ltd raised its position in Danaher Corporation by 7.6% in the first quarter. Intermede Investment Partners Ltd now owns 437,308 shares of the conglomerate’s stock valued at $37,403,000 after buying an additional 30,793 shares in the last quarter. Hedge funds and other institutional investors own 75.74% of the company’s stock.

Shares of Danaher Corporation (NYSE:DHR) traded up 0.95% during mid-day trading on Thursday, hitting $82.92. The stock had a trading volume of 869,828 shares. The firm’s 50 day moving average price is $82.08 and its 200 day moving average price is $84.16. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01. The company has a market cap of $57.60 billion, a P/E ratio of 26.47 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period in the previous year, the business earned $0.90 EPS. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. Analysts predict that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/danaher-corporation-dhr-stake-reduced-by-tompkins-financial-corp/1534509.html.

Several research firms have weighed in on DHR. Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, June 21st. Deutsche Bank AG reiterated a “buy” rating and set a $97.00 target price on shares of Danaher Corporation in a report on Wednesday, June 21st. Zacks Investment Research lowered Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Finally, Credit Suisse Group reiterated a “buy” rating and set a $93.00 target price on shares of Danaher Corporation in a report on Wednesday, May 24th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $91.76.

In related news, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now directly owns 18,245 shares in the company, valued at approximately $1,513,787.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold a total of 27,808 shares of company stock valued at $2,296,236 over the last quarter. 12.20% of the stock is owned by company insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.